1131540

Paul R. Harmatz, M.D. — FEI 3004936676

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
November 5, 2020
Fiscal Year
2021
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Oakland, CA (United States)

Additional Details

Clinical Investigator (CI)